Why the study?
Does intramyocardial delivery of Neuregulin-1β encapsulated in hydrogel improve ventricular function and cardiomyocyte proliferation in a murine model of ischemic cardiomyopathy?
Population
2-month-old mice with left anterior descending coronary artery ligation; Sprague-Dawley rats used for in…
Comparison
Neuregulin-1β encapsulated in hydrogel delivered… vs PBS, Neuregulin-1β alone, or hydrogel alone.
Design
Preclinical, randomized
Follow-up
2 weeks
Authors
Loading...
Supports NRG-1β hydrogel exploration in murine ischemic cardiomyopathy; leaves open clinical translation.
Does intramyocardial delivery of Neuregulin-1β encapsulated in hydrogel improve ventricular function and cardiomyocyte proliferation in a murine model of ischemic cardiomyopathy?
Targeted intramyocardial delivery of Neuregulin-1β via hydrogel enhances cardiomyocyte proliferation and improves left ventricular function in a murine model of ischemic cardiomyopathy, avoiding off-target exposure.
Cohen et al. (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: